Development of Streptomyces sp. FR-008 as an emerging chassis
Microbial-derived natural products are important in both the pharmaceutical industry and academic research. As the metabolic potential of original producer especially Streptomyces is often limited by slow growth rate, complicated cultivation profile, and unfeasible genetic manipulation, so exploring...
Main Authors: | Qian Liu, Liping Xiao, Yuanjie Zhou, Kunhua Deng, Gaoyi Tan, Yichao Han, Xinhua Liu, Zixin Deng, Tiangang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2016-09-01
|
Series: | Synthetic and Systems Biotechnology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405805X16300254 |
Similar Items
-
Identification of Mur34 as the novel negative regulator responsible for the biosynthesis of muraymycin in Streptomyces sp. NRRL30471.
by: Dongmei Xu, et al.
Published: (2013-01-01) -
Purification, Characterization and Application of a Protease from Pseudomonas sp. TKU008
by: Pei-Ting Liu, et al.
Published: (2009) -
Engineering and modification of microbial chassis for systems and synthetic biology
by: Haotian Chi, et al.
Published: (2019-03-01) -
Streptomyces avermitilis industrial strain as cell factory for Ivermectin B1a production
by: Qian Deng, et al.
Published: (2019-03-01) -
Recent advances in the elucidation of enzymatic function in natural product biosynthesis [version 1; referees: 2 approved]
by: Tan Gao-Yi, et al.
Published: (2015-12-01)